Cargando…

Unexpected Effect of IL-1β on the Function of GABA(A) Receptors in Pediatric Focal Cortical Dysplasia

Focal cortical dysplasia (FCD) type II is an epileptogenic malformation of the neocortex, as well as a leading cause of drug-resistant focal epilepsy in children and young adults. The synaptic dysfunctions leading to intractable seizures in this disease appear to have a tight relationship with the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alfano, Veronica, Romagnolo, Alessia, Mills, James D., Cifelli, Pierangelo, Gaeta, Alessandro, Morano, Alessandra, Mühlebner, Angelika, Aronica, Eleonora, Palma, Eleonora, Ruffolo, Gabriele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220988/ https://www.ncbi.nlm.nih.gov/pubmed/35741692 http://dx.doi.org/10.3390/brainsci12060807

Ejemplares similares

GABA(A) receptor function is enhanced by Interleukin-10 in human epileptogenic gangliogliomas and its effect is counteracted by Interleukin-1β
por: Ruffolo, Gabriele, et al.
Publicado: (2022)

Dissecting the Molecular Determinants of GABA(A) Receptors Current Rundown, a Hallmark of Refractory Human Epilepsy
por: Cifelli, Pierangelo, et al.
Publicado: (2021)

GABAergic Neurotransmission in Human Tissues Is Modulated by Cannabidiol
por: Ruffolo, Gabriele, et al.
Publicado: (2022)

Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
por: Cifelli, Pierangelo, et al.
Publicado: (2020)

Classical and Unexpected Effects of Ultra-Micronized PEA in Neuromuscular Function
por: Cifelli, Pierangelo, et al.
Publicado: (2022)

Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress
por: Zimmer, Till S., et al.
Publicado: (2021)

Long‐term seizure outcome after epilepsy surgery in patients with mild malformation of cortical development and focal cortical dysplasia
por: Veersema, Tim J., et al.
Publicado: (2018)

Genomic DNA methylation distinguishes subtypes of human focal cortical dysplasia
por: Kobow, Katja, et al.
Publicado: (2019)

Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex
por: Scholl, Theresa, et al.
Publicado: (2017)

Balloon cells promote immune system activation in focal cortical dysplasia type 2b
por: Zimmer, Till S., et al.
Publicado: (2021)

Cannabis in epilepsy: From clinical practice to basic research focusing on the possible role of cannabidivarin
por: Morano, Alessandra, et al.
Publicado: (2016)

Changes in the sensitivity of GABA(A) current rundown to drug treatments in a model of temporal lobe epilepsy
por: Cifelli, Pierangelo, et al.
Publicado: (2013)

Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions
por: Gruber, Victoria‐Elisabeth, et al.
Publicado: (2021)

Toward a refined genotype–phenotype classification scheme for the international consensus classification of Focal Cortical Dysplasia
por: Blumcke, Ingmar, et al.
Publicado: (2021)

Seven tesla MRI improves detection of focal cortical dysplasia in patients with refractory focal epilepsy
por: Veersema, Tim J., et al.
Publicado: (2017)

Modulation of GABAergic dysfunction due to SCN1A mutation linked to Hippocampal Sclerosis
por: Ruffolo, Gabriele, et al.
Publicado: (2020)

Contribution of Altered Endocannabinoid System to Overactive mTORC1 Signaling in Focal Cortical Dysplasia
por: García-Rincón, Daniel, et al.
Publicado: (2019)

The application of cortical layer markers in the evaluation of cortical dysplasias in epilepsy
por: Hadjivassiliou, George, et al.
Publicado: (2010)

Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects
por: Morano, Alessandra, et al.
Publicado: (2020)

Focal cortical dysplasia – review
por: Kabat, Joanna, et al.
Publicado: (2012)

MRI of focal cortical dysplasia
por: Urbach, Horst, et al.
Publicado: (2021)

Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study
por: Ceccanti, Marco, et al.
Publicado: (2022)

Focal corticarl dysplasia in epilepsy is associated with GABA increase
por: Gong, Tao, et al.
Publicado: (2021)

GABA(A) Receptor-Mediated Epileptogenicity in Focal Cortical Dysplasia (FCD) Depends on Age at Epilepsy Onset
por: Banerjee, Jyotirmoy, et al.
Publicado: (2020)

Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB
por: Boer, Karin, et al.
Publicado: (2008)

Editorial: Epilepsy and Neurodevelopmental Diseases
por: Ruffolo, Gabriele, et al.
Publicado: (2020)

Focal Cortical Dysplasia and Epilepsy Surgery
por: Lee, Sang Kun, et al.
Publicado: (2013)

Focal cortical dysplasia type 1
por: Coras, Roland, et al.
Publicado: (2021)

Focal Cortical Dysplasia with hippocampal sclerosis
por: Jadav, Devendra, et al.
Publicado: (2023)

Focal cortical dysplasias in autism spectrum disorders
por: Casanova, Manuel F, et al.
Publicado: (2013)

Rasmussen's encephalitis presenting as focal cortical dysplasia
por: O'Rourke, D.J., et al.
Publicado: (2014)

Calcium‐binding proteins in focal cortical dysplasia
por: Kuchukhidze, Giorgi, et al.
Publicado: (2015)

The Surgical and Cognitive Outcomes of Focal Cortical Dysplasia
por: Choi, Sun Ah, et al.
Publicado: (2019)

Not So Innocent Bystanders in Focal Cortical Dysplasia
por: Wang, Yu
Publicado: (2021)

Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models
por: Margotta, Cassandra, et al.
Publicado: (2023)

Diffusion tensor imaging discriminates focal cortical dysplasia from normal brain parenchyma and differentiates between focal cortical dysplasia types
por: Gennari, Antonio Giulio, et al.
Publicado: (2023)

Non-invasive treatment options for focal cortical dysplasia
por: WANG, TING-TING, et al.
Publicado: (2016)

“Within a minute” detection of focal cortical dysplasia
por: Urbach, Horst, et al.
Publicado: (2021)

Altered Extracellular Matrix as an Alternative Risk Factor for Epileptogenicity in Brain Tumors
por: de Jong, Jody M., et al.
Publicado: (2022)

Tuberous Sclerosis Complex as Disease Model for Investigating mTOR-Related Gliopathy During Epileptogenesis
por: Zimmer, Till S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ir1lf69do7sh61nnisifrm7fr7